Skip to content
10-K

Annual Report

Rich Pharmaceuticals, Inc.

0001662252-18-000076

← back to feed
Filed
Jul 17, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Jul 11, 2018 1.88B sh
Operating Cash Flow FY 2018 · Mar 31, 2018 −$508.48K
Operating Cash Flow FY 2018 · Mar 31, 2017 −$553.39K
Short Term Debt FY 2018 · Mar 31, 2018 $900K
Short Term Debt FY 2018 · Mar 31, 2017 $920K
Cash And Equivalents FY 2018 · Mar 31, 2018 $6.22K
Cash And Equivalents FY 2018 · Mar 31, 2017 $40.9K
Stockholders Equity FY 2018 · Mar 31, 2018 −$6.36M
Stockholders Equity FY 2018 · Mar 31, 2017 −$5.33M
Stockholders Equity FY 2018 · Mar 31, 2016 −$2.39M
Current Liabilities FY 2018 · Mar 31, 2018 $6.4M
Current Liabilities FY 2018 · Mar 31, 2017 $5.38M
Total Liabilities FY 2018 · Mar 31, 2018 $6.4M
Total Liabilities FY 2018 · Mar 31, 2017 $5.38M
Current Assets FY 2018 · Mar 31, 2018 $24.52K
Current Assets FY 2018 · Mar 31, 2017 $50.9K
Total Assets FY 2018 · Mar 31, 2018 $37.43K
Total Assets FY 2018 · Mar 31, 2017 $53.03K
Rd Expense FY 2018 · Mar 31, 2018 $332.63K
Rd Expense FY 2018 · Mar 31, 2017 $71.93K
Net Income FY 2018 · Mar 31, 2018 −$1.69M
Net Income FY 2018 · Mar 31, 2017 −$3.24M
Operating Income FY 2018 · Mar 31, 2018 −$1.34M
Operating Income FY 2018 · Mar 31, 2017 −$951.82K
Revenue FY 2018 · Mar 31, 2018 $115K